ch.oddb.org
 
Apotheken | Hôpital | Interactions | LiMA | Médecin | Médicaments | Services | T. de l'Autorisation
Information professionnelle sur Elfabrio 20 mg/10 ml:Chiesi SA
Information professionnelle complèteDDDAfficher les changementsimprimé 
Composit.Forme gal.Indic./emploiPosolog./mode d'empl.Contre-Ind.PrécautionsInteract.Grossesse
Apt.conduiteEffets indésir.SurdosagePropriétésPharm.cinét.Donn.précl.RemarquesNum. Swissmedic
PrésentationsTitulaireMise à jour 
A16AB20 - Pegunigalsidase AlfaATC-DDD Version 2016. Source: WHO
A - Alimentary Tract and Metabolism
 
A16 - Other Alimentary Tract and Metabolism Products
 
A16A - Other Alimentary Tract and Metabolism Products

This group comprises all products acting on the alimentary tract and metabolism which cannot be classified in the preceding groups. V03 - All other therapeutic products, should also be considered.
Nutrients are classified in V06 - General nutrients.

A16AB - Enzymes

This group includes gene therapy products resulting in the expression of specific enzymes.

A16AB20 - Pegunigalsidase Alfa
2025 ©ywesee GmbH
Einstellungen | Aide | FAQ | Identification | Contact | Home